Skip to content

Increasing Potassium Intake in Hypertensive Individuals

Adequate Intake of Potassium Does Not Cause Hyperkalemia in Hypertensive Individuals on Medications That Antagonize the Renin Angiotensin Aldosterone System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02759367
Enrollment
20
Registered
2016-05-03
Start date
2008-03-31
Completion date
2015-06-30
Last updated
2017-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Nutrition, Potassium

Brief summary

This study evaluates the safety of increasing dietary potassium intake in a hypertensive population that may be at risk for hyperkalemia.

Detailed description

The blood pressure lowering benefits of increasing dietary potassium (K⁺) are well known. As such dietary recommendations for hypertension focus on a diet rich in high K⁺ food sources such as fruits and vegetables. An important theme to be addressed is the safety of achieving high dietary K⁺ intake in hypertensive individuals who are also receiving medical therapy that might predispose to elevated serum K⁺ levels (hyperkalemia). The purpose of this study was to assess the impact of aggressively increasing dietary K⁺ on serum K⁺ concentrations in hypertensive individuals with intact renal function medicated with RAAS blocking drugs. The investigators hypothesized that dietary K⁺ supplementation would not provoke hyperkalemia despite treatment with either an angiotensin converting enzyme (ACEi) or an angiotensin receptor blocker (ARB). The investigators conducted an open controlled clinical trial in 20 hypertensive subjects with normal renal function who were randomized to a usual diet group (UD n=10), or a high potassium diet group (HKD, n= 10). Fruits and vegetables were used to increase potassium intake. All participants were on an ACEi or and ARB. Serum potassium concentration, 3- day food records and 24 Hour urine collections were completed at baseline and at the end of the 4-week study.

Interventions

An increase in consumption of high potassium fruits and vegetables

Sponsors

Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Treating physicians and participants were not blinded to randomization. Investigators performing randomization and analysis of dietary intake were blinded.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Medically treated hypertension as diagnosed Hypertension was established by the participant's cardiologist or if recruited from the online community hypertension was self-reported and confirmed by study investigators based on participant's medical prescription. * Treatment with an beta blocker, ACE inhibitor, or angiotensin receptor blocker without any adjustment over the previous 3 months * K+ intake at baseline of less than 80 mmol/day (food diary of 24 hour food recall).

Exclusion criteria

* Patients with an episode of acute coronary syndrome, or revascularization within the previous 3 months will not be included. * Serum K+ concentration 5.0 mmol/L * Serum creatinine \> 130 mmol/L. * Inability to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Serum potassium concentration4 weeks

Secondary

MeasureTime frameDescription
24 hour urinary potassium excretion4 weeks
3 day dietary food diary4 weeksFood record will assess marco and mirco nutrient intake.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026